Literature DB >> 21682744

Eosinophils: multifaceted biological properties and roles in health and disease.

Hirohito Kita1.   

Abstract

Eosinophils are leukocytes resident in mucosal tissues. During T-helper 2 (Th2)-type inflammation, eosinophils are recruited from bone marrow and blood to the sites of immune response. While eosinophils have been considered end-stage cells involved in host protection against parasite infection and immunopathology in hypersensitivity disease, recent studies changed this perspective. Eosinophils are now considered multifunctional leukocytes involved in tissue homeostasis, modulation of adaptive immune responses, and innate immunity to certain microbes. Eosinophils are capable of producing immunoregulatory cytokines and are actively involved in regulation of Th2-type immune responses. However, such new information does not preclude earlier observations showing that eosinophils, in particular human eosinophils, are also effector cells with proinflammatory and destructive capabilities. Eosinophils with activation phenotypes are observed in biological specimens from patients with disease, and deposition of eosinophil products is readily seen in the affected tissues from these patients. Therefore, it would be reasonable to consider the eosinophil a multifaceted leukocyte that contributes to various physiological and pathological processes depending on their location and activation status. This review summarizes the emerging concept of the multifaceted immunobiology of eosinophils and discusses the roles of eosinophils in health and disease and the challenges and perspectives in the field.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682744      PMCID: PMC3139217          DOI: 10.1111/j.1600-065X.2011.01026.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  197 in total

1.  Eosinophil cationic protein.

Authors:  E Boix
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

2.  Eosinophil-derived neurotoxin.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

3.  Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic protein.

Authors:  P Popken-Harris; M McGrogan; D A Loegering; J L Checkel; H Kubo; L L Thomas; J N Moy; L Sottrup-Jensen; J L Snable; M T Kikuchi
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

4.  A crucial role for beta 2 integrin in the activation of eosinophils stimulated by IgG.

Authors:  M Kaneko; S Horie; M Kato; G J Gleich; H Kita
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

5.  Functional characterization of P2Y and P2X receptors in human eosinophils.

Authors:  M Idzko; S Dichmann; E Panther; D Ferrari; Y Herouy; C Virchow ; W Luttmann; F Di Virgilio; J Norgauer
Journal:  J Cell Physiol       Date:  2001-09       Impact factor: 6.384

6.  Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation.

Authors:  P R Burgel; S C Lazarus; D C Tam; I F Ueki; K Atabai; M Birch; J A Nadel
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

7.  Substrates and products of eosinophil peroxidase.

Authors:  C J van Dalen; A J Kettle
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

8.  C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.

Authors:  P J Daffern; P H Pfeifer; J A Ember; T E Hugli
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

9.  Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.

Authors:  H Kita; R I Abu-Ghazaleh; S Sur; G J Gleich
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

10.  Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils.

Authors:  M Nonaka; R Nonaka; K Woolley; E Adelroth; K Miura; Y Okhawara; M Glibetic; K Nakano; P O'Byrne; J Dolovich
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

View more
  94 in total

1.  B lymphocytes regulate airway granulocytic inflammation and cytokine production in a murine model of fungal allergic asthma.

Authors:  Sumit Ghosh; Scott A Hoselton; Scott V Asbach; Breanne N Steffan; Steve B Wanjara; Glenn P Dorsam; Jane M Schuh
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

Review 2.  Eosinophil crystalloid granules: structure, function, and beyond.

Authors:  Valdirene S Muniz; Peter F Weller; Josiane S Neves
Journal:  J Leukoc Biol       Date:  2012-06-06       Impact factor: 4.962

Review 3.  Aquaporin 4 and neuromyelitis optica.

Authors:  Marios C Papadopoulos; A S Verkman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

Review 4.  Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation.

Authors:  Shigeharu Ueki; Takahiro Tokunaga; Shigeharu Fujieda; Kohei Honda; Makoto Hirokawa; Lisa A Spencer; Peter F Weller
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

5.  Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation.

Authors:  Alice Soragni; Shida Yousefi; Christina Stoeckle; Angela B Soriaga; Michael R Sawaya; Evelyne Kozlowski; Inès Schmid; Susanne Radonjic-Hoesli; Sebastien Boutet; Garth J Williams; Marc Messerschmidt; M Marvin Seibert; Duilio Cascio; Nadia A Zatsepin; Manfred Burghammer; Christian Riekel; Jacques-Philippe Colletier; Roland Riek; David S Eisenberg; Hans-Uwe Simon
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

Review 6.  The Regulatory Function of Eosinophils.

Authors:  Ting Wen; Marc E Rothenberg
Journal:  Microbiol Spectr       Date:  2016-10

7.  Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase.

Authors:  Stephen D Zucker; Megan E Vogel; Tammy L Kindel; Darcey L H Smith; Gila Idelman; Uri Avissar; Ganesh Kakarlapudi; Michelle E Masnovi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-17       Impact factor: 4.052

8.  Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells.

Authors:  Rafael Carretero; Ibrahim M Sektioglu; Natalio Garbi; Oscar C Salgado; Philipp Beckhove; Günter J Hämmerling
Journal:  Nat Immunol       Date:  2015-04-27       Impact factor: 25.606

9.  Misregulation of suppressors of cytokine signaling in eosinophilic esophagitis.

Authors:  Ma Paz Zafra; Natally Cancelliere; Pablo Rodríguez del Río; Mónica Ruiz-García; Laura Estévez; Victoria Andregnette; Silvia Sánchez-García; Ana Fiandor; Elena Collantes; Joaquín Sastre; Santiago Quirce; María Dolores Ibáñez; Victoria del Pozo
Journal:  J Gastroenterol       Date:  2012-12-11       Impact factor: 7.527

10.  Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7.

Authors:  David Pulido; Marc Torrent; David Andreu; M Victoria Nogués; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.